Follow The Filings

NERV Minerva Neurosciences

Minerva Neurosciences earnings company data as of 1:03 PM ET 11/17

  • 0 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS -0.18 -0.19 Miss
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
8-K 3.03,5.03,5.07,9.01
424B5
8-K 1.01,8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A
8-K 8.01
8-K 5.02,7.01,8.01,9.01
8-K 2.02,9.01
10-K

Insider forms

Forms 3, 4 and 5 from EDGAR, 3 rows shown

Filed Form Detail Links
4 Period Nov 2, 2026
4 Period Aug 3, 2026
4 Period Jun 3, 2026 (3 forms)

6 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf